195 related articles for article (PubMed ID: 20703228)
1. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study.
Kanno A; Metoki H; Kikuya M; Terawaki H; Hara A; Hashimoto T; Asayama K; Inoue R; Shishido Y; Nakayama M; Totsune K; Ohkubo T; Imai Y
Hypertens Res; 2010 Nov; 33(11):1192-8. PubMed ID: 20703228
[TBL] [Abstract][Full Text] [Related]
2. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study.
Terawaki H; Metoki H; Nakayama M; Ohkubo T; Kikuya M; Asayama K; Inoue R; Hoshi H; Ito S; Imai Y
Hypertens Res; 2008 Dec; 31(12):2129-35. PubMed ID: 19139602
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
5. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study.
Hara A; Ohkubo T; Kikuya M; Shintani Y; Obara T; Metoki H; Inoue R; Asayama K; Hashimoto T; Harasawa T; Aono Y; Otani H; Tanaka K; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
J Hypertens; 2007 Feb; 25(2):321-7. PubMed ID: 17211239
[TBL] [Abstract][Full Text] [Related]
6. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
[TBL] [Abstract][Full Text] [Related]
7. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
[TBL] [Abstract][Full Text] [Related]
8. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
[TBL] [Abstract][Full Text] [Related]
9. Relationship of dysregulation of glucose metabolism with white-coat hypertension: the Ohasama study.
Hosaka M; Mimura A; Asayama K; Ohkubo T; Hayashi K; Kikuya M; Sato M; Hashimoto T; Kanno A; Hara A; Obara T; Metoki H; Inoue R; Hoshi H; Satoh H; Oka Y; Imai Y
Hypertens Res; 2010 Sep; 33(9):937-43. PubMed ID: 20631718
[TBL] [Abstract][Full Text] [Related]
10. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
11. Effects of age on hypertensive status in patients with chronic kidney disease.
Minutolo R; Borrelli S; Chiodini P; Scigliano R; Bellizzi V; Cianciaruso B; Nappi F; Zamboli P; Catapano F; Conte G; De Nicola L
J Hypertens; 2007 Nov; 25(11):2325-33. PubMed ID: 17921829
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
[TBL] [Abstract][Full Text] [Related]
13. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.
Satoh M; Asayama K; Kikuya M; Inoue R; Metoki H; Hosaka M; Tsubota-Utsugi M; Obara T; Ishiguro A; Murakami K; Matsuda A; Yasui D; Murakami T; Mano N; Imai Y; Ohkubo T
Hypertension; 2016 Jan; 67(1):48-55. PubMed ID: 26527046
[TBL] [Abstract][Full Text] [Related]
15. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study.
Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y
Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698
[TBL] [Abstract][Full Text] [Related]
16. Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese: the Ohasama study.
Hirose T; Totsune K; Nakashige Y; Metoki H; Kikuya M; Ohkubo T; Hara A; Satoh M; Inoue R; Asayama K; Kondo T; Kamide K; Katsuya T; Ogihara T; Izumi S; Rakugi H; Takahashi K; Imai Y
Hypertens Res; 2011 Dec; 34(12):1327-32. PubMed ID: 21832999
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of sustained hypertension in white-coat or masked hypertension.
Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
20. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly.
Wada M; Nagasawa H; Iseki C; Takahashi Y; Sato H; Arawaka S; Kawanami T; Kurita K; Daimon M; Kato T
J Neurol Sci; 2008 Sep; 272(1-2):36-42. PubMed ID: 18541269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
